Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

277 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prospective, randomized, multicenter, double-blind placebo-controlled trial comparing adjuvant interferon alfa and isotretinoin with interferon alfa alone in stage IIA and IIB melanoma: European Cooperative Adjuvant Melanoma Treatment Study Group.
Richtig E, Soyer HP, Posch M, Mossbacher U, Bauer P, Teban L, Svolba G, Wolf IH, Fritsch P, Zelger B, Volc-Platzer B, Gebhart W, Mischer P, Steiner A, Pachinger W, Hintner H, Gschnait F, Rappersberger K, Pilarski P, Pehamberger H; European Cooperative Adjuvant Melanoma Treatment Study Group. Richtig E, et al. Among authors: pehamberger h. J Clin Oncol. 2005 Dec 1;23(34):8655-63. doi: 10.1200/JCO.2004.00.8128. Epub 2005 Oct 31. J Clin Oncol. 2005. PMID: 16260701 Clinical Trial.
Increased nuclear volume in metastasizing "thick" melanomas.
Mossbacher U, Knollmayer S, Binder M, Steiner A, Wolff K, Pehamberger H. Mossbacher U, et al. Among authors: pehamberger h. J Invest Dermatol. 1996 Mar;106(3):437-40. doi: 10.1111/1523-1747.ep12343580. J Invest Dermatol. 1996. PMID: 8648173 Free article.
Temozolomide and interferon alpha 2b in metastatic melanoma stage IV.
Richtig E, Hofmann-Wellenhof R, Pehamberger H, Forstinger Ch, Wolff K, Mischer P, Raml J, Fritsch P, Zelger B, Ratzinger G, Koller J, Lang A, Konrad K, Kindermann-Glebowski E, Seeber A, Steiner A, Fialla R, Pachinger W, Kos C, Klein G, Kehrer H, Kerl H, Ulmer H, Smolle J. Richtig E, et al. Among authors: pehamberger h. Br J Dermatol. 2004 Jul;151(1):91-8. doi: 10.1111/j.1365-2133.2004.06019.x. Br J Dermatol. 2004. PMID: 15270876 Clinical Trial.
Adjuvant treatment with pegylated interferon α-2a versus low-dose interferon α-2a in patients with high-risk melanoma: a randomized phase III DeCOG trial.
Eigentler TK, Gutzmer R, Hauschild A, Heinzerling L, Schadendorf D, Nashan D, Hölzle E, Kiecker F, Becker J, Sunderkötter C, Moll I, Richtig E, Pönitzsch I, Pehamberger H, Kaufmann R, Pföhler C, Vogt T, Berking C, Praxmarer M, Garbe C; Dermatologic Cooperative Oncology Group (DeCOG). Eigentler TK, et al. Among authors: pehamberger h. Ann Oncol. 2016 Aug;27(8):1625-32. doi: 10.1093/annonc/mdw225. Epub 2016 Jun 10. Ann Oncol. 2016. PMID: 27287206 Free article. Clinical Trial.
Diffuse melanosis in metastatic malignant melanoma.
Steiner A, Rappersberger K, Groh V, Pehamberger H. Steiner A, et al. Among authors: pehamberger h. J Am Acad Dermatol. 1991 Apr;24(4):625-8. doi: 10.1016/0190-9622(91)70096-k. J Am Acad Dermatol. 1991. PMID: 2033142
Erlotinib and bevacizumab have synergistic activity against melanoma.
Schicher N, Paulitschke V, Swoboda A, Kunstfeld R, Loewe R, Pilarski P, Pehamberger H, Hoeller C. Schicher N, et al. Among authors: pehamberger h. Clin Cancer Res. 2009 May 15;15(10):3495-502. doi: 10.1158/1078-0432.CCR-08-2407. Epub 2009 May 15. Clin Cancer Res. 2009. PMID: 19447871
277 results